During the past week I saw a ton of commercials for prescription medications. I am not sure exactly why but there sure seems to be an increase during the fall season. In the Diabetes category I counted no less than 14 different commercials  and that does not include the ones …

For those who cannot afford to pay for the new insulins ($250), do you recommend going back to NPH ($25/vial) and Regular insulins ($25/vial)? Follow the link to respond!

As a diabetes educator and pharmacist, I have had a lot of success helping patients improve their diabetes care. But at the end of the day, I get to go home diabetes free. This week, one of my pals and a pharmacist educator is sharing his professional and personal opinions …

Female, 32 years of age, type 1 diabetes, presented with Stage II partial thickness ulcer between 1st and 2nd toe R foot, and several Stage I areas on both feet. She had recently traveled and had bought several pair of new shoes for her trip.

This week, Associate Medical Editor Joy Pape wraps up her discussion with R. Keith Campbell, MBA, at the 2015 ADA Sessions in Boston. In this segment, he talks about his 60+ years of experience as a type 1 diabetes patient and how what he has learned over the years influences his view of his diabetes today.

Simple screening tests will identify most secondary causes of hyperlipidemia.

This week, Associate Medical Editor Joy Pape continues her discussion with R. Keith Campbell, MBA, at the 2015 ADA Sessions in Boston. In this segment, he shares his advice with other healthcare providers in regards to how to help their patients. He advocates for patient education now to mitigate the expensive complications that could happen later.

This week, Associate Medical Editor Joy Pape meets with R. Keith Campbell, MBA, professor emeritus of Diabetes Care/Pharmacology at Washington State University at the 2015 ADA Sessions in Boston to discuss the latest interesting developments in diabetes care and management.

In this week's Homerun Slides, we look at the pro and contra arguments for forcing of early Insulin Therapy in patients with Type 2 Diabetes...

In this week’s Homerun Slides, we look at SGLT2 Inhibition as a novel treatment strategy for type 2 diabetes.